These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8295464)

  • 1. Epstein-Barr virus lytic cycle spreads via cell fusion in a nasopharyngeal carcinoma hybrid cell line.
    Yoshizaki T; Takimoto T; Takeshita H; Tanaka S; Furukawa M; Seiki M; Sato H
    Laryngoscope; 1994 Jan; 104(1 Pt 1):91-4. PubMed ID: 8295464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the Epstein-Barr virus (EBV) receptor on the surface of cells infected with EBV derived from nasopharyngeal carcinoma.
    Takimoto T; Umeda R
    Acta Virol; 1989 Aug; 33(4):314-9. PubMed ID: 2574937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superinfection of epithelial hybrid cells (D98/HR-1, NPC-KT, and A2L/AH) with Epstein-Barr virus and the relationship to the C3d receptor.
    Takimoto T; Sato H; Ogura H; Miyawaki T; Glaser R
    Cancer Res; 1986 May; 46(5):2541-4. PubMed ID: 3008992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytopathic effects induced by Epstein-Barr virus replication in epithelial nasopharyngeal carcinoma hybrid cells.
    Sato H; Takimoto T; Tanaka S; Ogura H; Shiraishi K; Tanaka J
    J Virol; 1989 Aug; 63(8):3555-9. PubMed ID: 2545926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumorigenicity of nasopharyngeal carcinoma hybrid cell line.
    Takimoto T; Ogura H; Ohno S; Umeda R; Hatano M
    J Natl Cancer Inst; 1984 Sep; 73(3):711-5. PubMed ID: 6088881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of Epstein-Barr virus derived from a nasopharyngeal carcinoma that has transforming and lytic properties.
    Sato H; Takimoto T; Ogura H; Tanaka J; Hatano M; Glaser R
    J Natl Cancer Inst; 1986 Jun; 76(6):1019-24. PubMed ID: 3012175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in the ability of cells to fuse are mediated by strains of Epstein-Barr virus.
    Takimoto T; Sato H; Ogura H; Tanaka S; Masuda K; Ishikawa S; Umeda R
    Laryngoscope; 1989 Oct; 99(10 Pt 1):1075-80. PubMed ID: 2552238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanism of Epstein-Barr virus infection in nasopharyngeal carcinoma cells.
    Lin CT; Lin CR; Tan GK; Chen W; Dee AN; Chan WY
    Am J Pathol; 1997 May; 150(5):1745-56. PubMed ID: 9137098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of transforming and early antigen-inducing Epstein-Barr virus from nasopharyngeal carcinoma hybrid cells (NPC-KT).
    Takimoto T; Ogura H; Sato H; Umeda R; Hatano M
    J Natl Cancer Inst; 1985 Jan; 74(1):57-60. PubMed ID: 2982054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus in somatic cell hybrids between mouse cells and human nasopharyngeal carcinoma cells.
    Steplewski Z; Koprowski H; Andersson-Anvret M; Klein G
    J Cell Physiol; 1978 Oct; 97(1):1-8. PubMed ID: 213442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus in nontumorigenic and tumorigenic nasopharyngeal carcinoma (NPC) somatic cell hybrids.
    Staczek J; Steplewski Z; Weinmann R; Klein G; Koprowski H
    J Cell Physiol; 1981 Jun; 107(3):391-8. PubMed ID: 6265479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
    Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
    Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Epstein-Barr virus receptor on two nasopharyngeal carcinoma model cell lines.
    Takimoto T; Umeda R; Glaser R
    Acta Virol; 1989 Aug; 33(4):375-7. PubMed ID: 2574946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro production of stable Epstein-Barr virus-positive epithelial cell clones which resemble the virus:cell interaction observed in nasopharyngeal carcinoma.
    Knox PG; Li QX; Rickinson AB; Young LS
    Virology; 1996 Jan; 215(1):40-50. PubMed ID: 8553585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell fusion by nasopharyngeal carcinoma-derived Epstein-Barr virus.
    Takimoto T; Sato H; Ogura H; Miyazaki T
    Arch Otolaryngol Head Neck Surg; 1987 May; 113(5):510-3. PubMed ID: 3032215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of nasopharyngeal carcinoma growth by RTA-expressing baculovirus vectors containing oriP.
    Wang L; Shan L; Lo KW; Yin J; Zhang Y; Sun R; Zhong J
    J Gene Med; 2008 Oct; 10(10):1124-33. PubMed ID: 18642396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies.
    Chang Y; Sheen TS; Lu J; Huang YT; Chen JY; Yang CS; Tsai CH
    Lab Invest; 1998 Jun; 78(6):715-26. PubMed ID: 9645762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal versus polyclonal Epstein-Barr virus infection in nasopharyngeal carcinoma cell lines.
    Lin CT; Chen W; Hsu MM; Dee AN
    Lab Invest; 1997 Jun; 76(6):793-8. PubMed ID: 9194855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic role of Epstein-Barr virus-encoded small RNAs (EBERs) in nasopharyngeal carcinoma.
    Yoshizaki T; Endo K; Ren Q; Wakisaka N; Murono S; Kondo S; Sato H; Furukawa M
    Auris Nasus Larynx; 2007 Mar; 34(1):73-8. PubMed ID: 17129696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus (EBV)-encoded BARF1 gene is expressed in nasopharyngeal carcinoma and EBV-associated gastric carcinoma tissues in the absence of lytic gene expression.
    Seto E; Yang L; Middeldorp J; Sheen TS; Chen JY; Fukayama M; Eizuru Y; Ooka T; Takada K
    J Med Virol; 2005 May; 76(1):82-8. PubMed ID: 15778977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.